Actionable news
0
All posts from Actionable news
Actionable news in MNK: MALLINCKRODT PUBLIC LIMITED COMPANY,

Mallinckrodt to Present at UBS Global Healthcare Conference

CHESTERFIELD, United Kingdom, April 27, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals MNK, -2.04% a leading global specialty biopharmaceutical company, will present on Tuesday, May 24, 2016, at the UBS Global Healthcare Conference at the Grand Hyatt New York, 109 E. 42 [nd] St., New York.

Matthew Harbaugh, Senior Vice President and Chief Financial Officer, and Cole Lannum, Senior Vice President of Investor Strategy and Investor Relations Officer, will represent the company in a fireside chat session at 2:30 p.m. Eastern time.

Individuals who cannot attend the meeting in person can find webcast information at: http://www.mallinckrodt.com/investors. A replay will also be available following the meeting.

ABOUT MALLINCKRODTMallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies, as well as nuclear...


More